Organic compounds -- part of the class 532-570 series inventions 05/07

20070123702 - Oligonucleotdies having a-dna form and b-dna form conformational geometry: Modified oligonucleotides containing both A-form conformation geometry and B-from conformation geometry nucleotides are disclosed. The B-form geometry allows the oligonucleotide to serve as substrates for RNase H when bound to a target nucleic acid strand. The A-form geometry imparts properties to the oligonucleotide that modulate binding affinity and nuclease resistance.... Agent: Woodcock Washburn LLP

20070123703 - Chloral-free dca in oligonucleotide synthesis: A process of manufacturing oligonucleotides includes a 5′-deblocking step in which the 5-blocking group is removed with dichloroacetic acid that is essentially free of chloral. The process is useful for making oligonucleotides that are substantially free of chloral adducts.... Agent: Woodcock Washburn LLP

20070117968 - Metal binding proteins and associated methods: Metal binding proteins, associated compositions and methods for their production and use are disclosed. The metal binding proteins included have amino acid sequences analogous to at least one metal binding protein, and conservative amino acid substitutions thereof from a brine shrimp (Artemia). Also provided are the associated nucleic acid sequences... Agent: Kirkpatrick & Lockhart Preston Gates Ellis LLP

20070117969 - Pth receptor and screening assay utilizing the same: The invention provides a novel PTH receptor polypeptide, rΔNt, characterized by a deletion of the extracellular amino-terminus, ligand binding domain of the receptor. Additionally disclosed are nucleic acid molecules encoding the receptor. The receptor has a minimal domain for ligand binding and is useful in screening assays designed for the... Agent: Sterne, Kessler, Goldstein & Fox P.l.l.c.

20070117970 - Vmp-like sequences of pathogenic borrelia: The present invention relates to DNA sequences encoding Vmp-like polypeptides of pathogenic Borrelia, the use of the DNA sequences in recombinant vectors to express polypeptides, the encoded amino acid sequences, application of the DNA and amino acid sequences to the production of polypeptides as antigens for immunoprophylaxis, immunotherapy, and immunodiagnosis.... Agent: Fulbright & Jaworski L.L.P.

20070117971 - Cellulose based optical film material and method for forming the same: wherein R1 is —H or —C(O)R4, R4 is alkyl or aryl; R2 is —C(O)R5, R5 is alkyl or aryl; R3 comprises one of the group consisting of: phosphinate based group, phosphonate based group, phosphonamide based group, phosphate based group, phosphoramide based group, carbamate based group, carbonate based group, and ester... Agent: Wpat, PC

20070117972 - Materials and methods for the purification of polyelectrolytes, particularly nucleic acids: This invention describes materials and methods usable for the purification of polyelectrolytes, such as nucleic acids and proteins. The materials of the invention are separation media that possess pH-dependent groups with pKa value in the range of about 5 to about 7. Separation of the nucleic acids or proteins from... Agent: Invitrogen Corporation C/o Intellevate

20070112183 - Chitin oligomer composition and/or chitosan oligomer composition and processes for preparation thereof: This invention aims to develop a chitin oligomer composition and/or a chitosan oligomer composition wherein the content of an oligomer from a trimer to a decamer is 60% or more, and to develop a process for preparing the above-mentioned oligomer composition. The object of the invention can be achieved by... Agent: Armstrong, Kratz, Quintos, Hanson & Brooks, LLP

20070112184 - Production of carrageenan and carrageenan products: The methods of the present invention prepare carrageenan products from processed seaweed material having a solids content of less than 25% by weight solids, using shear stress treatment. The carrageenan products comprise at least about 60% by weight of carrageenan and at least about 2% by weight of acid insoluble... Agent: John M. Sheehan Patent Administrator

20070112185 - Method for preparing a cellulose ether: The invention relates to a method for preparing a cellulose ether. The method comprises mixing cellulose with an ionic liquid solvent to dissolve the cellulose, and then treating the dissolved cellulose with an etherifying agent in the presence of an inorganic base to form a cellulose ether, and subsequently separating... Agent: Birch Stewart Kolasch & Birch

20070112186 - Method for selective carbohydrate oxidation using supported gold catalysts: The present invention relates to a method for the selective oxidation of a carbohydrate in the presence of a gold catalyst which includes nanodispersed gold particles on a metal oxide support, to a method for the selective oxidation of an oligosaccharide in the presence of a gold catalyst which comprises... Agent: Ostrolenk Faber Gerb & Soffen

20070112187 - Separation process: The invention relates to a process of recovering arabinose and optionally other monosaccharides from vegetable fiber rich in heteropolymeric arabinose, such as gum arabic. Said other monosaccharides are typically selected from galactose and rhamnose. The process of the invention comprises controlled hydrolysis of the arabinose-rich vegetable fiber and fractionation of... Agent: Scully Scott Murphy & Presser, PC

20070106068 - Human cytokine receptor: Cytokines and their receptors have proven usefulness in both basic research and as therapeutics. The present invention provides a new human cytokine receptor designated as “Zcytor16.”... Agent: Zymogenetics, Inc. Intellectual Property Department

20070106069 - Non-human primate fc receptors and methods of use: The invention provides isolated non-human primate Fc receptor polypeptides, the nucleic acid molecules encoding the Fc receptor polypeptides, and the processes for production of recombinant forms of the Fc receptor polypeptides, including fusions, variants, and derivatives thereof. The invention also provides methods for evaluating the safety, efficacy and biological properties... Agent: Merchant & Gould PC

20070106070 - Novel forms of t cell costimulatory molecules and uses therefor: Novel structural forms of T cell costimulatory molecules are described. These structural forms comprise a novel structural domain or have a structural domain deleted or added. The structural forms correspond to naturally-occurring alternatively spliced forms of T cell costimulatory molecules or variants thereof which can be produced by standard recombinant... Agent: Foley Hoag, LLP Patent Group, World Trade Center West

20070106071 - Methods for nucleic acid isolation and instruments for nucleic acid isolation: The present invention relates to a technique for efficient isolation of long nucleic acids and short nucleic acids from a sample containing long nucleic acids and short nucleic acids via safe and convenient operations. Specifically, long nucleic acids and short nucleic acids are isolated from a sample containing nucleic acids... Agent: Mcdermott Will & Emery LLP

20070100136 - Monomer compositions for the synthesis of rna, methods of synthesis, and methods of deprotection: Nucleotide monomers, polynucleotides, methods of making making each, methods of deprotecting each, and the like are disclosed herein.... Agent: Agilent Technologies Inc.

20070100138 - Monomer compositions for the synthesis of polynucleotides, methods of synthesis, and methods of deprotection: Nucleotide monomers, polynucleotides, methods of making each, and methods of deprotecting each, are disclosed.... Agent: Agilent Technologies Inc.

20070100137 - Solutions, methods, and processes for deprotection of polynucleotides: Methods of deprotecting polynucleotides are disclosed.... Agent: Agilent Technologies Inc.

20070100139 - Methods for chlorinating sucrose-6-ester: Methods for chlorinating sucrose-6-esters to produce 1′,4,6′-trichlorosucrose-6-esters include providing a reaction mixture in a temperature-controlled vessel at a temperature less than about 65° C., the reaction mixture comprising sucrose-6-ester, a tertiary amide, and a chloroformiminium chloride salt, which forms an O-alkylformiminium chloride adduct with the hydroxyl groups of the sucrose-6-ester.... Agent: Snell & Wilmer L.L.P. (main)